Publication | Open Access

Thymic Carcinoid Responds to Neoadjuvant Therapy with Sunitinib and Octreotide: A Case Report

Neoadjuvant TherapyMedicineImmunologyPathologyCancer TreatmentThyroid HormoneImmunotherapyOncologyMalignant DiseaseThymic Carcinoid RespondsCancer ResearchCase Report